Clinical Trial Update: A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

View source ↗

Summary

A long-term clinical trial is evaluating potential liver toxicity associated with TURALIO (pexidartinib) treatment in patients with Tenosynovial Giant Cell Tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tenosynovial Giant Cell Tumor

Drugs mentioned

• TURALIO (pexidartinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hepatotoxicity, Tenosynovial Giant Cell Tumor | Status: RECRUITING